The Val-CARD Trial (Val-CARD)
A Randomised Controlled Trial of Pre-surgery Sodium ValpRoate, for the Prevention of Organ Injury in Cardiac Surgery: THE Val-CARD TRIAL
Sponsor: University of Leicester
A PHASE1/PHASE2 clinical study on Cardiac Valve Disease and Coronary Artery Disease, this trial is ongoing. The trial is conducted by University of Leicester and has accumulated 11 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
11 versions recorded-
Jan 2026 — Present [monthly]
Unknown PHASE1/PHASE2
Status: Recruiting → Unknown
-
Sep 2024 — Jan 2026 [monthly]
Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Dec 2023 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
Status: Unknown Status → Recruiting
-
May 2023 — Dec 2023 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
▶ Show 6 earlier versions
-
Jun 2021 — May 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2021 — Jun 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2019 — Feb 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Nov 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Leicester
For direct contact, visit the study record on ClinicalTrials.gov .